Filing Details
- Accession Number:
- 0001104659-11-064407
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-11-15 19:26:56
- Reporting Period:
- 2011-11-11
- Filing Date:
- 2011-11-15
- Accepted Time:
- 2011-11-15 19:26:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 881524 | Vivus Inc | VVUS | Pharmaceutical Preparations (2834) | 943136179 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1341526 | Wesley Day | 1172 Castro Street Mountain View CA 94040 | Vp, Clinical Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-11-11 | 3,400 | $3.13 | 20,200 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2011-11-11 | 20,042 | $3.28 | 40,242 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-11-11 | 23,442 | $9.87 | 16,800 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2011-11-11 | 3,400 | $0.00 | 3,400 | $3.13 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2011-11-11 | 20,042 | $0.00 | 20,042 | $3.28 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2016-01-30 | No | 4 | M | Direct | |
| 0 | 2016-05-09 | No | 4 | M | Direct |
Footnotes
- Includes 16,800 shares previously acquired.
- The sale price reported in column 4 of Table I represents the weighted average sale price of the shares sold ranging from $9.79 to $9.95 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- The option is fully vested and immediately exercisable.
Billionaire Hedge Funds
